Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Long-term Depression01:05

Long-term Depression

33.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.6K
Long-term Depression01:03

Long-term Depression

3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.5K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.0K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.0K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

834
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
834
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.9K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prolonged In Vitro Exposure to Methylmalonic Acid Induces Inflammation, Glutamate Metabolism Disruption, and Alters Functional Gene Expression in C6 Astroglial Cells.

Neurotoxicity research·2026
Same author

Ultra-Processed Foods and Diet Quality in Long COVID: Associations with Symptom Burden, DNA Damage, and Inflammation.

Mutagenesis·2026
Same author

Exposure to SARS-CoV-2 Spike protein during development induces astrogliosis, synapse loss and long-term cognitive dysfunction in mice.

Brain, behavior, and immunity·2026
Same author

Early Effects of Poly(I:C)-induced Neuroinflammation on Hippocampal Astrocyte Function and Glycolytic Metabolism.

Journal of neurochemistry·2026
Same author

Increased type 3 deiodinase reduces hippocampal T3 signaling and is associated with cognitive impairment in a sporadic Alzheimer's disease animal model.

Scientific reports·2026
Same author

Preventive Aerobic Training Protects Against Doxorubicin-Induced Cardiotoxicity by Preserving Redox Status and Attenuating Cardiac Stress-Related Signaling.

Cells·2026

Related Experiment Video

Updated: Mar 19, 2026

DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density
09:10

DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density

Published on: July 22, 2022

3.8K

Changes in the complement system are involved in synaptic pruning in major depressive disorder.

João Henrique Correa Kanan1, Larissa D Bobermin2, Vanessa-Fernanda da Silva3

  • 1Department of Microbiology, Immunology and Parasitology, Institute of Basic Health Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.

Journal of Neuroimmunology
|March 18, 2026
PubMed
Summary

The complement system aids brain health by clearing synapses, a process vital for preventing neurodegeneration and major depressive disorder. Understanding glial complement proteins is key for future diagnostics and therapies.

More Related Videos

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

18.9K
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.3K

Related Experiment Videos

Last Updated: Mar 19, 2026

DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density
09:10

DetectSyn: A Rapid, Unbiased Fluorescent Method to Detect Changes in Synapse Density

Published on: July 22, 2022

3.8K
The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

18.9K
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.3K

Area of Science:

  • Neuroimmunology
  • Molecular and Cellular Neuroscience
  • Psychiatric Disorders

Background:

  • The complement system, a crucial part of innate immunity, involves liver-synthesized proteins that tag invaders for destruction and aid tissue remodeling.
  • In the central nervous system (CNS), complement proteins produced by microglia and astrocytes mediate synaptic pruning, essential for neural development and plasticity.
  • Aberrant synaptic pruning is implicated in neurodegenerative diseases and psychiatric disorders, including major depressive disorder (MDD).

Purpose of the Study:

  • To review the role of the complement system within the CNS, with a specific focus on its involvement in major depressive disorder.
  • To highlight the critical contributions of astrocytes and other glial cells to complement-mediated processes in the CNS.
  • To underscore the necessity for advancing the understanding of glial complement system proteins for diagnostic and therapeutic applications in CNS disorders.

Main Methods:

  • Literature review synthesizing current research on the complement system's function in the CNS.
  • Focus on studies examining complement involvement in synaptic remodeling and major depressive disorder.
  • Emphasis on the roles of astrocytes and microglia in CNS complement pathways.

Main Results:

  • The complement system plays a dual role in the CNS: facilitating normal synaptic pruning and contributing to pathology in neurodegenerative and psychiatric conditions.
  • Astrocytes are significant producers of complement proteins in the CNS, influencing synaptic function and elimination.
  • Dysregulation of glial complement activity is increasingly recognized as a factor in the pathophysiology of major depressive disorder.

Conclusions:

  • The complement system, particularly glial-derived components, is integral to CNS health and disease, especially in major depressive disorder.
  • Targeting specific glial complement pathways presents a promising avenue for developing novel diagnostic tools and therapeutic strategies for psychiatric disorders.
  • Further research into the precise mechanisms of glial complement proteins is essential for clinical translation.